Bleichroeder’s Aptose Biosciences APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-121,366
Closed -$382K – 83
2025
Q1
$382K Buy
121,366
+38,033
+46% +$185K 0.1% 48
2024
Q4
$563K Buy
+83,333
New +$759K 0.14% 36

Other funds holding APTO

Bleichroeder's APTO Position: Q2 2025 in Review

Bleichroeder sold out of Aptose Biosciences (APTO) in Q2 2025, closing a stake of 121,366 shares — an estimated $382K sold.

Bleichroeder first reported a position in APTO in Q4 2024 and held it in 2 quarters. The position peaked at $563K in Q4 2024. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • Bleichroeder reported no remaining Aptose Biosciences position as of Q2 2025 after selling out during the quarter.
  • Bleichroeder sold 121,366 Aptose Biosciences shares in Q2 2025, an estimated $382K.
  • Bleichroeder first reported a position in Aptose Biosciences in Q4 2024 and held it in 2 quarters.
  • Bleichroeder's Aptose Biosciences position peaked at $563K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences as of Q2 2025.

Based on Bleichroeder's 13F filing for Q2 2025, filed 14 Aug 2025.